EM-transcriptomic signature predicts drug response in advanced stages of high-grade serous ovarian carcinoma based on ascites-derived primary cultures
Article in Frontiers in Pharmacology (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (March 2024)
Article in Biological and Pharmaceutical Bulletin (July 2023)
Article in Journal of Immunology Research (March 2022)